- In April 2023, Glooko, Inc., a leading software company, entered into a global partnership with Hedia, a developer of insulin dosing algorithms. This collaboration aims to create an interoperable solution that combines remote patient monitoring, connected care, and digital therapeutic technologies. By doing so, they seek to enhance access for individuals with Type 1 and Type 2 diabetes who require guidance on bolus insulin dosing
- In May 2023, Medtronic plc, a leading global healthcare technology company, announced definitive agreements to acquire EOFlow Co. Ltd., known for its innovative wearable insulin patches. This acquisition aims to enhance automated insulin delivery capabilities and streamline diabetes treatment for patients. By incorporating EOFlow's technology, Medtronic seeks to bolster its position in the industry while expanding its product offerings to better serve individuals managing diabetes
- In October 2021, Roche partnered with the Zur Rose Group to enhance support for individuals with diabetes and their caregivers in managing daily medications. This collaboration aims to integrate Roche Diabetes Care’s solutions with those of leading third-party providers, creating a more comprehensive healthcare ecosystem. By connecting their innovative healthcare products, Roche and Zur Rose Group seek to improve the overall quality of life for people living with diabetes
Frequently Asked Questions
The market is segmented based on Segmentation, By Devices (Smart Glucose Meters, Continuous Glucose Monitoring Systems, Smart Insulin Pens, Smart Insulin Pumps, and Closed Loop Systems), Devices Type (Handheld Devices, and Wearable Devices), Application (Diabetes and Blood Glucose Tracking Apps, Obesity and Diet Management Apps), Diabetes Type (Type 1 Diabetes and Type 2 Diabetes), End Use (Home Healthcare, Hospitals, and Specialty Diabetes Clinics) – Industry Trends and Forecast to 2031
.
The Global Smart Diabetes Management Market size was valued at USD 7.44 USD Billion in 2023.
The Global Smart Diabetes Management Market is projected to grow at a CAGR of 15% during the forecast period of 2024 to 2031.
The major players operating in the market include Abbott, PHC Holdings Corporation, WellDoc , Sanofi, Dexcom , DarioHealth Corp, Medtronic, B. Braun SE, F. Hoffmann La Roche Ltd, Insulet Corporation, Ascensia Diabetes Care Holdings AG, Tidepool, Tandem Diabetes Care, LifeScan, AgaMatrix, Glooko , DarioHealth.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
